Author

Joshua X. Hoffman

GlaxoSmithKline (United Kingdom)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:database / resource· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Research Focus:GWAS / association mapping· 1 Organism:human· 1 Research Focus:imputation· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Alan R. ShuldineriD· 1 shared Alexander E. LopeziD· 1 shared Alexander H. LiiD· 1 shared Alicia C. Hawes· 1 shared Andrew L. BlumenfeldiD· 1 shared Anthony MarckettaiD· 1 shared Aris BarasiD· 1 shared Aris N. EconomidesiD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alan R. ShuldinerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Whole exome sequencing and characterization of coding variation in 49,960 individuals in the UK Biobank

Cristopher V. Van Hout, Ioanna Tachmazidou, Joshua Backman, Joshua X. Hoffman, Bin Ye, Ashutosh K. Pandey, Claudia G. Gonzaga-Jauregui, Shareef Khalid, Daren Liu, Nilanjana Banerjee, Alexander H. Li, O’Dushlaine Colm, Anthony Marcketta, Jeffrey C. Staples, Claudia Schurmann, , Aris Baras

Exomes of 49,960 UK Biobank participants reveal 231,631 predicted loss-of-function variants (>10-fold more than imputed data); burden tests implicate PIEZO1, MEPE, and COL6A1 in disease traits.

bioRxiv · Mar 9, 2019 · PreprintGenomics✦ In-depth digest